Navigation Links
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Date:4/29/2009

n the U.S. and an estimated 246 million adults worldwide.(i,ii) Approximately 90-95 percent of those affected have type 2 diabetes. Diabetes is the fifth leading cause of death by disease in the U.S. and costs approximately $174 billion per year in direct and indirect medical expenses.(iii)

According to the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey, approximately 60 percent of people with diabetes do not achieve their target blood sugar levels with their current treatment regimen.(iv) In addition, 85 percent of type 2 diabetes patients are overweight and 55 percent are considered obese.(v) Data support that weight loss (even a modest amount) supports patients in their efforts to achieve and sustain glycemic control.(vi,vii)

About BYETTA(R) (exenatide) injection

BYETTA is the first and only FDA-approved incretin mimetic for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone glucagon like peptide-1 (GLP-1). GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain. BYETTA is approved by the FDA for use by people with type 2 diabetes who are unsuccessful at controlling their blood sugar levels. BYETTA is an add-on therapy for people currently using metformin, a sulfonylurea, or a thiazolidinedione. BYETTA provides sustained A1C control and low incidence of hypoglycemia when used with metformin or a thiazolidinedione, with potential weight loss. BYETTA is not a weight loss product. BYETTA was approved in April 2005 and has been used by more than one million patients since its introduction. For full prescribing information, visit www.BYETTA.com.

Important Safety Information for BYETTA

BYETTA improves glucose (blood sugar) control in adults with
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
4. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
5. Lilly and Glenmark Pharmaceuticals Announce License Agreement
6. Lilly Receives NCQA Design Certification for Depression Care Management Program
7. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
8. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
9. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
10. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
11. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- According to a new market research ... and Photopheresis) by Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood ... to 2020", published by MarketsandMarkets, the global Apheresis Market ... growing at a CAGR of 11.2% during the forecast ... 139 Tables and 45 F igures spread through ...
(Date:9/4/2015)... , September 4, 2015 Future ... Allergic Rhinitis drugs - new ... Where is the market for allergic rhinitis drugs ... Visiongain ,s new report shows you potential revenues ... prospects. Our 326 page report provides 273 ...
(Date:9/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gbd3bt/stability_testing ) ... of Pharmaceuticals (London, UK - December 2-3, 2015)" ... comprehensive two day seminar delegates will: - ... suitable for global arketing - Be able to ... and facilities - Know how to save resource ...
Breaking Medicine Technology:Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2
... -- MAP Pharmaceuticals, Inc. (Nasdaq: ... the Phase 3 FREEDOM-301 study of  LEVADEX™ orally inhaled ... titled MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study ... online and will appear in the April edition, Volume ...
... 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... of medical devices worldwide, announced today that it will ... in Shenzhen, China from April 16 to April 19, ... devices from its three core product segments: patient monitoring ...
Cached Medicine Technology:Data from FREEDOM-301 Study for LEVADEX™ Orally Inhaled Migraine Drug Published in 'Headache' 2Data from FREEDOM-301 Study for LEVADEX™ Orally Inhaled Migraine Drug Published in 'Headache' 3Data from FREEDOM-301 Study for LEVADEX™ Orally Inhaled Migraine Drug Published in 'Headache' 4Mindray Medical to Exhibit New Products at 65th China International Medical Equipment Fair 2
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability ... of the Year” awards at this year’s Microsoft Worldwide Partner Conference that was ... of the Year” Award Winner for Data Platform services, the 2015 HP and ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Many consumers are looking for a quick and ... their solution. , The patent-pending K Med Cups provide a quick and simple way to ... relieve a cold, flu or cough. As a result, they enhance comfort and health. The ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC ... first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. The ... and feature 30 cottage or “pocket” homes. In this community, adults will live ...
(Date:9/4/2015)... NC (PRWEB) , ... September 04, 2015 , ... ... filtration products, has a Labor Day offer that cannot be passed up. ... stock up on necessary air and water filtration product replacements. Take advantage of ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to announce a ... norm not the exception. , St. Jude was recently named one of the nation’s ... making it one of only 10 hospitals in the state to earn the distinction. ...
Breaking Medicine News(10 mins):Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3
... SATURDAY, Jan. 16 (HealthDay News) -- Allergy vaccinations reduce ... one-third and drug prescription costs by 16 percent, according ... the medical claims for 2,770 children with hay fever ... of 11,000 children with allergic rhinitis who didn,t receive ...
... ... the cost of their Diabetes Panel to $89 for the month of January. Symptoms of ... your hands or feet. , ... TX (Vocus) January 16, 2010 -- ANY LAB TEST NOW North Dallas locations have lowered the ...
... , OAKLAND, Calif. , Jan. 15 ... to four national disaster relief organizations to provide aid ... .  The nonprofit health care organization has wired the funding ... International, and is providing expertise and support to U.S. disaster ...
... , MARINA DEL RAY, Calif., Jan. 15 Dr. ... to announce he is sending much needed assistance to the Haitian earthquake ... doctors and staff are leaving Jan 25 & 26. The ... be able to treat hundreds of patients a day at their clinic. ...
... OAKLAND, Calif. , Jan. 15 Nearly 7,500 registered nurses ...  believed to be the largest outpouring of RN volunteers in U.S. history, ... the clock to find locations for the nurses to deploy on the ... through the NNU program as well. , View the attached ...
... , SOUTHFIELD, Mich. , Jan. 15 As ... relief organization, Life for Relief and Development (Life) in partnership with ... a prominent humanitarian relief organization in the United Arab Emirates ... the victims of the recent earthquake in Haiti . , ...
Cached Medicine News:Health News:Shots Relieve Children's Hay Fever, Cut Expenses 2Health News:ANY LAB TEST NOW North Dallas Lowers Diabetes Testing to $89 2Health News:Kaiser Permanente Donates $500,000 for Relief Efforts Following Earthquake in Haiti 2Health News:Kaiser Permanente Donates $500,000 for Relief Efforts Following Earthquake in Haiti 3Health News:Heritage Provider Network, Dr. Richard Merkin, Comes to the Aid of Haitian Earthquake Victims 2Health News:Nearly 7,500 RNs Ready to Deploy to Haiti 2Health News:Life for Relief & Dubai Charity to Send $1.25 Million in Emergency Relief for Haiti Earthquake Victims 2
... Your patient will be more comfortable, and ... tube stabilization more secure and to avoid ... and untying of twill ties, consider the ... and neonate/infant sizes, the narrow fastener tabs ...
... Designed for ease of use and patient ... smooth edges for comfort and is available ... to a perfect fit. For hard to ... trach collar to your specifications. Don't just ...
... alternate care facilities with a wide ... offer the finest in nursing convenience ... guidance of experienced nursing personnel, these ... is required for efficient and quick ...
... kit features a patented Per-fit™ flexible PVC ... a low-profile cuff specifically designed to reduce ... the patients anatomy. The kit s unique ... tube snugly, allowing for an easier transition ...
Medicine Products: